BCPC — Balchem Income Statement
0.000.00%
- $5.35bn
- $5.44bn
- $1.04bn
Annual income statement for Balchem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 799 | 942 | 922 | 954 | 1,037 |
| Cost of Revenue | |||||
| Gross Profit | 243 | 280 | 302 | 336 | 371 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 672 | 797 | 763 | 771 | 828 |
| Operating Profit | 128 | 145 | 159 | 183 | 209 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 125 | 134 | 137 | 166 | 199 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 96.1 | 105 | 109 | 128 | 155 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 96.1 | 105 | 109 | 128 | 155 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 96.1 | 105 | 109 | 128 | 155 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.97 | 3.32 | 3.29 | 3.95 | 4.78 |
| Dividends per Share |